Prescient is…

…harnessing hindsight, insight and foresight to unlock healthcare innovation and scientific breakthroughs. Our strategic and collaborative consulting helps global biopharma organizations to improve people’s lives.

Talk to our team

About Us

Where science, strategy and future thinking meet

We’re a global team of bioscience specialists providing integrated, competitive and customer insights driven strategic consultancy across the full drug life cycle.

We build from a foundation of deep science and clinical-based insights. But while science and strategy may underpin our business, what drives it are deep, collaborative relationships. True partnerships.

A true partnership involves going further and digging deeper in search of transformational insights, diverse perspectives and industry-challenging ideas – and applying them with real value.

This blend of deep relationships, strategic rigor and scientific expertise unlocks the full potential of healthcare innovation. Innovation with the power to significantly improve people’s lives around the world.

Environmental, Social and Governance

At Prescient we combine hindsight + insight + foresight to develop prescience, the ability to know, or strongly suggest, what the future will hold, and to shape actions that positively impact that future.

In our day-to-day lives, we experience the changes in our planet, and looking to the future, we know we need to act now to make a difference.

We strive to take actions that positively impact us as a people and a planet. Our Environmental, Social and Governance program details our commitment to making responsible decisions for our people and our planet.

Our Codes of Conduct provide a basic understanding of the standards of ethical conduct that Prescient requires around the world. Our Global Code of Conduct (“Global Code”) focuses on the actions of our employees, while our Supplier Code of Conduct (“Supplier Code”) defines expectations for our providers.

Download the 2023 ESG Annual Impact Report
Download the 2022 ESG Annual Impact Report
Download the Global Code
Download the Supplier Code


Three areas of expertise. From integrated specialists.

Our services are split into three core areas of expertise. We’re structured to deliver our support as one integrated team or working within our individual disciplines. This means we’re highly adaptable in pursuit of the best possible outcome.




Prescient brings deep scientific and strategic understanding to partner with medical VPs and directors at a portfolio planning and evidence-generation strategy level. With this expertise, we can provide organizational development to build future-proofed medical affairs capabilities.

Learn more



Our commercial support delivers brand strategies and customer research that’s built on deep scientific and clinical knowledge.

Learn more



The present is dynamic. An ever-changing environment that, for your molecule to succeed, demands prescient thinking at the intersection of the scientific, competitor and customer perspectives. That’s where we operate.

Learn more


This is how we see it

The different perspectives we bring to clients help them to focus on the future with clarity of mind. Our blog is written to do exactly the same. Industry insights from the edge of tomorrow.

White Paper

Jun 04, 2024

Navigating Your Medical Narrative: A Proactive Guide

Understanding how medical narratives adapt and transform in response to external events and different phases of a product's life cycle is crucial for effective communication and engagement. This white paper offers valuable insights and practical guidance for navigating these complexities...

Read more

Blog Post

May 23, 2024

How Project Optimus has Reshaped Oncology Drug Development: Opportunities and Challenges

In the wake of the FDA’s Project Optimus, an initiative that aims to reform approaches to dose selection and optimization for oncology drugs, clinical development for cancer therapies is likely to undergo a prolonged and costly transition away from the conventional paradigm...

Read more

White Paper

Apr 25, 2024

Will TL-1A be the Game Changer in IBD? The IBD Treatment Landscape is Still Looking for Answers

Explore the evolving treatment landscape of inflammatory bowel disease (IBD) in our latest white paper. Discover the latest advancements and potential game-changers in patient care...

Read more